ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Remedy Robotics, a San Francisco healthcare AI company, raised $62M in Series B funding led by DCVC. The capital accelerates a pivotal clinical trial with the University of California and advances FDA approval for neurovascular intervention. The team deploys prototype N1 Systems across its clinical partner network.
Tap to vote and see what everyone thinks.
Summary by ByteBrief